QLM2011

Qilu Pharmaceutical (Hainan) Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	QLM2011
Sponsor	Qilu Pharmaceutical (Hainan) Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of QLM2011 in Subjects With Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

QLM2011 CI brief — competitive landscape report
QLM2011 updates RSS · CI watch RSS
Qilu Pharmaceutical (Hainan) Co., Ltd. portfolio CI